Completed NA INTERVENTIONAL 2-arm NCT02623101

Reflectance Confocal Microscopy in Basal Cell Carcinoma

In Vivo Reflectance Confocal Microscopy, a Novel Non-invasive Tool for Diagnosing Skin Cancer - A Randomized Controlled Trial

Sponsor: Mavig GmbH

Conditions Carcinoma, Basal Cell

Interventions Punch biopsy Reflectance confocal microscopy Surgical excision

Updated 7 times since 2017 Last updated: Sep 18, 2019 Started: Dec 1, 2015 Primary completion: May 31, 2019 Completion: May 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Carcinoma, Basal Cell and is currently completed. Mavig GmbH leads this study, which shows 7 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2022 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Mar 2022 [monthly]

Completed NA
Oct 2019 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 2 earlier versions

Jun 2018 — Oct 2019 [monthly]

Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mavig GmbH
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Data source: Radboud University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nijmegen, Netherlands
• Velp, Netherlands